What it's sold for

Libido / sexual function
Erectile function
Energy

What has actually been tested

Hypoactive Sexual Desire Disorder
Female Sexual Arousal Disorder
Kidney Disease
Lactating Mother
Nausea
Obesity
Sexual Arousal Disorder

Is it studied for what it's sold for?

Each claim below is matched against the condition and title fields of every registered trial. Not listed means no trial names it as a studied condition — not that it has been disproven, and not that no trial touches it indirectly.

Not listed Libido / sexual function

Not listed Erectile function

Not listed Energy

Every trial on record

Every registered human study we can find for PT-141. Click any ID to read the original record — we would rather you checked us than trusted us.

Trial ID	Title	Condition	Phase	Status	Enrolled
NCT00425256	Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)	Sexual Arousal Disorder	Phase 2	Completed	—
NCT04943068	A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)	Hypoactive Sexual Desire Disorder	Phase 3	Completed	193
NCT06867835	Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk	Lactating Mother	Phase 4	Completed	10
NCT02338960	2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder	Hypoactive Sexual Desire Disorder	Phase 3	Completed	714
NCT01382719	Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder	Female Sexual Arousal Disorder, Hypoactive Sexual Desire Disorder	Phase 2	Completed	612
NCT03973047	Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran	Nausea	Phase 1	Completed	228
NCT02333071	1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder	Hypoactive Sexual Desire Disorder	Phase 3	Completed	723
NCT05709444	A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease	Kidney Disease	Phase 2	Completed	16
NCT04179734	Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder	Hypoactive Sexual Desire Disorder	Phase 4	Completed	40
NCT06565611	A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity	Obesity	Phase 2	Running, closed to new participants	108

—Read this

A trial count is not a verdict

These numbers describe how much has been formally studied in humans, not whether something works or is safe for you. A compound can be tested for one condition and sold for another — which is usually the story. This page is automated aggregation from public registries; no physician has reviewed it. Take anything here to a clinician.

Common questions about PT-141

How many human trials does PT-141 have?

10. That is the number of registered interventional human studies we can find, each listed on this page with a link to its original record.

Is PT-141 FDA approved?

Yes, but read the detail: FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Grey-market "PT-141" is not the approved product. An approval for one condition is not an approval for everything it is marketed for.

What is PT-141 actually being tested for?

Registered studies cover: sexual arousal disorder, hypoactive sexual desire disorder, lactating mother. Compare that to what it is marketed for — the two lists are often different, which is the whole point of this page.

Where does this data come from?

ClinicalTrials.gov, the US public registry of clinical studies. We count interventional human studies only — observational studies are not evidence of effect. Every trial on this page links to its original record so you can check us rather than trust us.